Foreign Affairs

Trump's 200% tariff plan may be a bitter pill for US consumers; Dr Reddy's warns of costlier medicines

· 22 July 2026 · 2 min read
Trump's 200% tariff plan may be a bitter pill for US consumers; Dr Reddy's warns of costlier medicines

The Times of India has reported a new India-focused foreign affairs development: “Trump's 200% tariff plan may be a bitter pill for US consumers; Dr Reddy's warns of costlier medicines.” The publisher's feed describes the story as follows: <![CDATA[The United States plans significant tariffs on imported generic medicines. These duties will rise to 200% in the coming years. Dr Reddy's Laboratories anticipates higher medicine prices for American consumers. Shifting manufacturing to the US is curr

Original reporting by The Times of IndiaRead the full story

Intellectual Janata displays only original summaries of externally sourced news and links readers to the original publisher.

#foreign-affairs#india

Related reading

IJP
News Brief
Foreign secretary Vikram Misri flags tariff move in talks with US undersecretary
Foreign Affairs·The Economic Times·25 Sep 2026

Foreign secretary Vikram Misri flags tariff move in talks with US undersecretary

Read full story →
IJP
News Brief
India and the plausible multilateralism of BRICS
Foreign Affairs·The Hindu·25 Sep 2026

India and the plausible multilateralism of BRICS

Read full story →
IJP
News Brief
CEA flags US friction, energy shocks, and missing AI play as India’s key near-term risks
Foreign Affairs·Mint·25 Sep 2026

CEA flags US friction, energy shocks, and missing AI play as India’s key near-term risks

Read full story →
IJP
News Brief
India, 17 others reserve rights to join Russia’s CBAM dispute with EU as third party at WTO
Foreign Affairs·The Economic Times·25 Sep 2026

India, 17 others reserve rights to join Russia’s CBAM dispute with EU as third party at WTO

Read full story →